mayoclinic.org (trusted non-journal) Cleveland Clinic
11 , M111.014563 (2012)
Applications in Research As a standard diluent for peptide and protein reconstitution Preparation of injectable-grade research compounds for in vitro or ex vivo studies Investigation of peptide and biologic stability following reconstitution Formulation testing and solvent compatibility studies Multi-use experimental workflows requiring bacteriostatic protection Specifications Summary Purity: Manufactured to specification Appearance: Clear, colourless sterile solution Solvent Type: Bacteriostatic aqueous diluent Preservative: Benzyl alcohol 0.9% (w/v) Solubility: Fully miscible with water and aqueous buffers Storage: Controlled room temperature Pack Size: 10 ml Handling, Use & Stability Use aseptic technique when accessing vial contents Avoid contact with non-sterile surfaces Do not use if solution becomes cloudy or discoloured Seal vial promptly after use to maintain sterility Avoid exposure to excessive heat or prolonged light Do not freeze Precautions & Notes Not all peptides or biologics are compatible with benzyl alcohol
Cohen blends consummate artistry with a science-backed approach to your care, ensuring elegant, nuanced outcomes that telegraph your innate beauty.
This includes a range of treatments, such as artificial insemination (AI), in vitro fertilizationembryo transfer (IVFET), and derivative technologies
Proposed explanations include: Tissue retention of peptide or active metabolites Persistent activation of signaling cascades beyond peptide clearance Potential for active metabolites with prolonged tissue residence Excretion Pathways Limited data on elimination routes indicates: Likely renal excretion of peptide fragments based on molecular weight and water solubility Potential hepatic contribution to metabolite clearance No evidence of accumulation in chronic dosing studies in rats and monkeys Degradation products eliminated without evidence of toxic metabolite formation The dramatic disconnect between three-minute plasma half-life and prolonged metabolic effects remains one of the most intriguing and poorly understood aspects of AOD-9604 pharmacology, requiring further mechanistic investigation
